Researchers evaluated overall and progression-free survival among older adults with advanced biliary tract cancer who received combination chemotherapy.

A randomized trial compared short-term androgen deprivation with high-dose radiotherapy (STADT-RT) and high-dose radiation therapy alone in localized prostate cancer.

These results support the view that a considerable proportion of cancers arise from stochastic processes, rather than being solely driven by hereditary factors or environmental exposures,” the ...

Researchers sought to determine whether isatuximab and cemiplimab would be safe and effective for patients with relapsed/refractory extranodal NK/T-cell lymphoma.

A 24-hour nursing supervisor shift report built on the REDCap platform improved how information moves across the hospital’s operation.

Carboplatin plus etoposide, with or without focal treatments, may be safe and effective for patients with high-risk intraocular retinoblastoma, according to phase 2 results published in Cancer ...

Researchers assessed the safety and efficacy of combining glofitamab with R-CHOP or Pola-R-CHP among patients with high-risk LBCL aged 65 years or younger.

Haplo-cord HCT offered improved 2-year OS (72.7% vs 61.0%) and DFS (67.0% vs 49.6%) compared with haplo HCT alone.

These results demonstrate the importance of considering financial factors at the time of cancer diagnosis and highlight the need for financial assistance programs that prevent medical debt,” ...

Researchers evaluated whether interferon-α nasal spray reduces the incidence of COVID-19 or other respiratory viral infections among adults with cancer.

Investigators searched for predictors of insensitivity to neoadjuvant cisplatin-based chemotherapy among patients with muscle-invasive bladder cancer.

Data from the HARMONi trial suggest that outcomes may differ between patients in China and those in North America or Europe.